Role of Estrogen and Progesterone in the Survival of Ovarian Tumors - A Study of the Human Ovarian Adenocarcinoma Cell Line OC-117-VGH

Based on the findings of decreased survival and/or growth in OC-117-VGH ovarian adenocarcinoma cells treated with either estrogen or progesterone, we suspect that both hormones act effectively against ER-negative and PR-negative ovarian cancer cells. These findings should lead to a reassessment of hormone therapy for ovarian cancers.